# Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico

> **NCT04145856** · PHASE4 · COMPLETED · sponsor: **Hospital Juarez de Mexico** · enrollment: 55 (actual)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** I31 probiotic
- **COMBINATION_PRODUCT:** I31 probiotic combined to Alverine/Simethicone
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04145856
- **Lead sponsor:** Hospital Juarez de Mexico
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-03
- **Primary completion:** 2019-05-02
- **Final completion:** 2019-08-27
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2020-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04145856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04145856, "Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04145856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*